220 related articles for article (PubMed ID: 37140166)
1. Familial Clonal Hematopoiesis in a Long Telomere Syndrome.
DeBoy EA; Tassia MG; Schratz KE; Yan SM; Cosner ZL; McNally EJ; Gable DL; Xiang Z; Lombard DB; Antonarakis ES; Gocke CD; McCoy RC; Armanios M
N Engl J Med; 2023 Jun; 388(26):2422-2433. PubMed ID: 37140166
[TBL] [Abstract][Full Text] [Related]
2. The enigma of excessively long telomeres in cancer: lessons learned from rare human POT1 variants.
Gong Y; Stock AJ; Liu Y
Curr Opin Genet Dev; 2020 Feb; 60():48-55. PubMed ID: 32155570
[TBL] [Abstract][Full Text] [Related]
3.
Shen E; Xiu J; Lopez GY; Bentley R; Jalali A; Heimberger AB; Bainbridge MN; Bondy ML; Walsh KM
J Med Genet; 2020 Oct; 57(10):664-670. PubMed ID: 31937561
[TBL] [Abstract][Full Text] [Related]
4. POT1 mutations cause differential effects on telomere length leading to opposing disease phenotypes.
Zade NH; Khattar E
J Cell Physiol; 2023 Jun; 238(6):1237-1255. PubMed ID: 37183325
[TBL] [Abstract][Full Text] [Related]
5. A POT1 mutation implicates defective telomere end fill-in and telomere truncations in Coats plus.
Takai H; Jenkinson E; Kabir S; Babul-Hirji R; Najm-Tehrani N; Chitayat DA; Crow YJ; de Lange T
Genes Dev; 2016 Apr; 30(7):812-26. PubMed ID: 27013236
[TBL] [Abstract][Full Text] [Related]
6. Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.
Wong K; Robles-Espinoza CD; Rodriguez D; Rudat SS; Puig S; Potrony M; Wong CC; Hewinson J; Aguilera P; Puig-Butille JA; Bressac-de Paillerets B; Zattara H; van der Weyden L; Fletcher CDM; Brenn T; Arends MJ; Quesada V; Newton-Bishop JA; Lopez-Otin C; Bishop DT; Harms PW; Johnson TM; Durham AB; Lombard DB; Adams DJ
JAMA Dermatol; 2019 May; 155(5):604-609. PubMed ID: 30586141
[TBL] [Abstract][Full Text] [Related]
7. Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders.
Schratz KE; Gaysinskaya V; Cosner ZL; DeBoy EA; Xiang Z; Kasch-Semenza L; Florea L; Shah PD; Armanios M
J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34343137
[TBL] [Abstract][Full Text] [Related]
8. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Shi J; Yang XR; Ballew B; Rotunno M; Calista D; Fargnoli MC; Ghiorzo P; Bressac-de Paillerets B; Nagore E; Avril MF; Caporaso NE; McMaster ML; Cullen M; Wang Z; Zhang X; ; ; ; Bruno W; Pastorino L; Queirolo P; Banuls-Roca J; Garcia-Casado Z; Vaysse A; Mohamdi H; Riazalhosseini Y; Foglio M; Jouenne F; Hua X; Hyland PL; Yin J; Vallabhaneni H; Chai W; Minghetti P; Pellegrini C; Ravichandran S; Eggermont A; Lathrop M; Peris K; Scarra GB; Landi G; Savage SA; Sampson JN; He J; Yeager M; Goldin LR; Demenais F; Chanock SJ; Tucker MA; Goldstein AM; Liu Y; Landi MT
Nat Genet; 2014 May; 46(5):482-6. PubMed ID: 24686846
[TBL] [Abstract][Full Text] [Related]
9. Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood.
Michler P; Schedel A; Witschas M; Friedrich UA; Wagener R; Mehtonen J; Brozou T; Menzel M; Walter C; Nabi D; Pearce G; Erlacher M; Göhring G; Dugas M; Heinäniemi M; Borkhardt A; Stölzel F; Hauer J; Auer F
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769003
[TBL] [Abstract][Full Text] [Related]
10. Functional diversity of human protection of telomeres 1 isoforms in telomere protection and cellular senescence.
Yang Q; Zhang R; Horikawa I; Fujita K; Afshar Y; Kokko A; Laiho P; Aaltonen LA; Harris CC
Cancer Res; 2007 Dec; 67(24):11677-86. PubMed ID: 18089797
[TBL] [Abstract][Full Text] [Related]
11. Recent emergence and extinction of the protection of telomeres 1c gene in Arabidopsis thaliana.
Kobayashi CR; Castillo-González C; Survotseva Y; Canal E; Nelson ADL; Shippen DE
Plant Cell Rep; 2019 Sep; 38(9):1081-1097. PubMed ID: 31134349
[TBL] [Abstract][Full Text] [Related]
12. TSPYL5 Depletion Induces Specific Death of ALT Cells through USP7-Dependent Proteasomal Degradation of POT1.
Episkopou H; Diman A; Claude E; Viceconte N; Decottignies A
Mol Cell; 2019 Aug; 75(3):469-482.e6. PubMed ID: 31278054
[TBL] [Abstract][Full Text] [Related]
13. Germline
Andreotti V; Vanni I; Pastorino L; Ghiorzo P; Bruno W
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254993
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated POT1 mutations lead to telomere elongation without induction of a DNA damage response.
Kim WT; Hennick K; Johnson J; Finnerty B; Choo S; Short SB; Drubin C; Forster R; McMaster ML; Hockemeyer D
EMBO J; 2021 Jun; 40(12):e107346. PubMed ID: 33934394
[TBL] [Abstract][Full Text] [Related]
15. POT1-TPP1 differentially regulates telomerase via POT1 His266 and as a function of single-stranded telomere DNA length.
Xu M; Kiselar J; Whited TL; Hernandez-Sanchez W; Taylor DJ
Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23527-23533. PubMed ID: 31685617
[TBL] [Abstract][Full Text] [Related]
16. Abnormal mRNA Expression Levels of Telomere-Binding Proteins Represent Biomarkers in Myelodysplastic Syndromes: A Case-Control Study.
Liu B; Yan R; Zhang J; Wang B; Sun H; Cui X
Turk J Haematol; 2017 Aug; 34(3):200-206. PubMed ID: 28404540
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.
Richard MA; Lupo PJ; Morton LM; Yasui YA; Sapkota YA; Arnold MA; Aubert G; Neglia JP; Turcotte LM; Leisenring WM; Sampson JN; Chanock SJ; Hudson MM; Armstrong GT; Robison LL; Bhatia S; Gramatges MM
PLoS One; 2020; 15(2):e0228887. PubMed ID: 32040538
[TBL] [Abstract][Full Text] [Related]
18. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
[TBL] [Abstract][Full Text] [Related]
19. TRF2 promotes dynamic and stepwise looping of POT1 bound telomeric overhang.
Paul T; Liou W; Cai X; Opresko PL; Myong S
Nucleic Acids Res; 2021 Dec; 49(21):12377-12393. PubMed ID: 34850123
[TBL] [Abstract][Full Text] [Related]
20. POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas.
Calvete O; Garcia-Pavia P; Domínguez F; Mosteiro L; Pérez-Cabornero L; Cantalapiedra D; Zorio E; Ramón Y Cajal T; Crespo-Leiro MG; Teulé Á; Lázaro C; Morente MM; Urioste M; Benitez J
J Am Heart Assoc; 2019 Sep; 8(18):e012875. PubMed ID: 31510873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
